Devyser Diagnostics AB (publ)

Total Valuation

Devyser Diagnostics AB (publ) carries a market capitalization of 985.90M, placing it among publicly traded companies globally. Its enterprise value stands at 2.05B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Devyser Diagnostics AB (publ) currently has 16.59M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 8.93, and the price-to-book ratio stands at -10.21.

Enterprise Valuation

Financial Position

Devyser Diagnostics AB (publ) maintains a current ratio of 2.89, meaning it holds 2.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 16.04, indicating elevated leverage, while an interest coverage ratio of -2.75 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Devyser Diagnostics AB (publ) has paid 2.70M in income taxes, reflecting an effective tax rate of 35.00.

Stock Price Statistics

Devyser Diagnostics AB (publ)'s stock has declined approximately -54.46154% over the past 52 weeks. The 50-day moving average sits at 90.77, while the 200-day moving average is 102.34.

Income Statement

Over the trailing twelve months, Devyser Diagnostics AB (publ) generated 235.10M in revenue and converted that into -45.60M in net income, yielding earnings per share of -2.72. EBITDA reached -34.90M, while operating income came in at -34.90M.

Balance Sheet

Devyser Diagnostics AB (publ) holds 100.40M in cash and equivalents against 54.20M in total debt, resulting in a net debt position of -100.00M. Total book value stands at -205.50M, with working capital of 141.50M providing operational flexibility.

Cash Flow

Devyser Diagnostics AB (publ) produced -20.00M in operating cash flow over the past twelve months. After subtracting -76.10M in capital expenditures, free cash flow totaled -96.10M - equivalent to -5.81 per share.

Margins

Devyser Diagnostics AB (publ) operates with a gross margin of 81.62, reflecting its pricing power and cost economics. The operating margin of -14.84 and net profit margin of -19.40 provide insight into operational efficiency.

Dividends & Yields

Scores

Devyser Diagnostics AB (publ) posts an Altman Z-Score of 10.23, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.